课题基金 / 基金详情

Novel strategies to target lung cancer metastasis to bone

Novel strategies to target lung cancer metastasis to bone
针对肺癌骨转移的新策略
批准号:
10646351
负责人:
GEORGE R. BECK
金额:
$17.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-15 至 2025-05-31
关键词:
A549AdenocarcinomaAdenocarcinoma In SituAllelesAntibodiesBehaviorBreastCalciumCancer Cell GrowthCancer ControlCancer EtiologyCancer PatientCause of DeathCell LineCell SurvivalCellsClinicalComplexConsumptionDataDiagnosisDietDietary InterventionDiseaseDisseminated Malignant NeoplasmElementsEnvironmentEtiologyEventFailureFemoral FracturesFractureFrequenciesGenetically Engineered MouseGrowthHomingHyperplasiaImageImmune systemIncidenceIntakeKRASG12DKnowledgeLinkLoxP-flanked alleleLuciferasesLungLung AdenocarcinomaMalignant NeoplasmsMalignant neoplasm of lungMetastatic Neoplasm to the BoneMethodologyMicroscopyMineralsModalityModelingMonitorMusNeoplasm MetastasisNutritionalOsteoporosisPainPharmaceutical PreparationsPhenotypePhosphotransferasesPhysiologicalPre-Clinical ModelPrevalencePreventionPrevention approachProcessPrognosisProstateRecoveryRegulationResolutionRisk FactorsSerumSiteSkeletonSoilTNFSF11 geneTestingTherapeuticTherapeutic StudiesTransgenic MiceTropismTumor PromotionTumor Suppressor ProteinsXenograft Modelbisphosphonatebonebone imagingbone lossbone metabolismbone turnovercancer cellcancer diagnosiscancer preventioncell behaviorcellular imagingcomorbiditydraining lymph nodedrug repurposingfracture riskhuman migrationimaging modalityin vivoinnovationinorganic phosphateinsightlanthanum carbonatelifestyle factorsmetastatic processmicroCTmouse modelneoplastic cellnovelnovel anticancer drugnovel strategiesnovel therapeutic interventionnutritionosteopontinpain reductionpharmacologicpre-clinicalpreventrelease factorsensorside effectskeletaltherapeutic targetthree dimensional cell culturetumortumor progression

项目摘要

项目成果

GEORGE R. BECK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Metastasis is the leading cause of death from cancer. Metastasis to bone represents a particularly poor prognosis. Unfortunately, the skeleton is one of the most common sites of metastasis for cancers such as breast, prostate and lung. Further, metastasis to bone results in significant pain, loss of mobility and increased fractures, among other comorbidities. The underlying mechanisms are incompletely understood and treatment options are mostly limited to attempting to reduce pain and fracture risk after diagnosis. Therefore, an enhanced understanding of the underlying etiology and/or a novel strategy to prevent or reduce bone metastasis would represent a significant advance to a field sorely in need of new options. One major obstacle to understanding, as well as developing therapeutic options for bone metastases is the paucity of pre-clinical models that faithfully recapitulate this multi-stage complex process. We have identified a novel genetically engineered mouse model in which to study lung cancer progression and metastasis to bone. Further, we believe we have identified a novel risk factor for cancer cell growth and survival as well as a factor that strongly influences the bone microenvironment in inorganic phosphate (Pi). Studies proposed herein will probe at the underlying mechanisms of bone metastasis combining a state-of-the-art mouse metastasis model, advanced microscopy and micro-computed tomography in the context of a novel and highly translational nutrition based prevention approach. Specifically, we will test the hypothesis that: The KrasG12D; Lkb1fl/fl; Rosa-luciferase mouse represents a model of spontaneous lung cancer metastasis to bone. Further, that this model can be used to study therapeutic and prevention modalities as well as provide mechanistic insight into this complex disease. To test this hypothesis we will: 1) therapeutically target spontaneous metastasis to bone using the KLLlenti mouse model, and 2) determine if differences in Pi transport drive a bone seeking phenotype. Impact: Results from the current proposal have the potential to provide new information about the mechanisms by which a common nutritional element might be manipulated to alter cell behavior related to cancer etiology as well as a better understanding of the skeletal environment which promotes tumor cell establishment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel strategies to target lung cancer metastasis to bone
  • 批准号:
    10513138
  • 项目类别:
  • 资助金额:
    $21.95万
  • 财政年份:
    2022
  • 负责人:
    GEORGE R. BECK
  • 依托单位:
ShEEP Request For A Pre-Clinical In-Vivo X-Ray Micro Computed-Tomography Scanner
  • 批准号:
    10178581
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    GEORGE R. BECK
  • 依托单位:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
  • 批准号:
    9280823
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    GEORGE R. BECK
  • 依托单位:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
  • 批准号:
    8974367
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    GEORGE R. BECK
  • 依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 项目类别:
    专项基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2008
  • 负责人:
    焦宇飞
  • 依托单位: